Source: MedGen UID: 22655⇩ Viral vaccine
Any vaccine preparation composed of a live,
attenuated, inactivated, killed or recombinant
virus. Administration of a viral vaccine is to
provide prophylaxis against viral disease or
used as a vehicle to treat cancers.
Adenovirus VaccineRecombinant Fowlpox-gp100p209rF-PSA/PSMA/TRICOMRotavirus vaccineYellow fever vaccine—antiviralSARS-CoV-2oral—antibodyimmunizationinfluenzadeletion
PRJNA264130 Responses to Varicella Zoster
PRJNA264131 Responses to Varicella Zoster
PRJNA146547 Synthetic double stranded RNA
reliably induces innate immunity similar to a live
viral vaccine in humans
32235848 Modification of Adenovirus vaccine
vector-induced immune responses by expression
of a signalling molecule.
32214704 Bioinformatical study on the
proteomics and evolution of SARS-CoV.
32209114 Porous gold nanoparticles for
attenuating infectivity of influenza A virus.
32194995 The outbreak of SARS-CoV-2pneumonia calls for viral vaccines.
31217437 Adenoviral vaccine targeting multiple
neoantigens as strategy to eradicate large
tumors combined with checkpoint blockade.
31211446 Differences in smolt status affect the
resistance of Atlantic salmon (Salmo salar L.)
against infectious pancreatic necrosis, while
vaccine-mediated protection is unaffected.
31163292 How the gut microbiome regulates
host immune responses to viral vaccines.
31127400 Large-scale microcarrier culture of
HEK293T cells and Vero cells in single-use
31121217 Exploitation of glycosylation in
enveloped virus pathobiology.
31113974 Thermal Stabilization of Viral
Vaccines in Low-Cost Sugar Films.
31110074 A Phase 1 Dose Escalation Trial of
BN-CV301, a Recombinant Poxviral Vaccine
Targeting MUC1 and CEA with Costimulatory
31104946 Influenza Antigen Engineering
Focuses Immune Responses to a Subdominant
but Broadly Protective Viral Epitope.
31096061 Nanoencapsulation of
inactivated-viral vaccine using chitosan
nanoparticles: Evaluation of its protective
efficacy and immune modulatory effects in olive
flounder (Paralichthys olivaceus) against viral
haemorrhagic septicaemia virus (VHSV)
31092579 The Effect of Age on the
Immunogenicity of the Live Attenuated Zoster
Vaccine Is Predicted by Baseline Regulatory T
Cells and VZV-Specific T Cell Immunity.
31047676 Semi-perfusion cultures of
suspension MDCK cells enable high cell
concentrations and efficient influenza A virus
31040832 Structural Vaccinology for Viral
31022927 Characterization of EIAV env
Quasispecies during Long-Term Passage In
Vitro: Gradual Loss of Pathogenicity.
30996103 Oral vaccination with
replication-competent adenovirus in mice
reveals the dissemination of the viral vaccine
beyond the gastrointestinal tract.
30996093 A genome-wide haploid genetic
screen identifies heparan sulfate-associated
genes and the macropinocytosis modulator
TMED10 as factors supporting vaccinia virus
30992598 Vaccine usage in western Canadian
30984178 Unveiling Integrated Functional
Pathways Leading to Enhanced Respiratory
Disease Associated With Inactivated
Respiratory Syncytial Viral Vaccine.
30946751 Correlation between herpes simplex
virus neutralizing antibody titers determined by
ELVIS cell and traditional plaque reduction
30945978 The vaccines-associated Arthus
30906919 From prevention to cure,
repurposing anti-viral vaccines for cancer
3204617 Safety and Immunogenicity Study of
DNA.HTI, MVA.HTI and ChAdOx1.HTI in
3202719 Duration of IPV Priming and Antibody
3148990 Study to Evaluate the
Immunogenicity, Reatogenicity and Safety of
Double Viral Vaccine (MR) for Measles and
2425410 Analysis of Viral Infections' Exposition
Preceding the Type 1 Diabetes (T1D)
Diagnostic in Children of the Isis-Diab Cohort.
Search for Explanations of of the Disease's
2415166 Influenza Challenge in Mood
2291263 Immunogenicity of Intramuscular
Inactivated Poliovirus Vaccine
2196285 Study to Evaluate Safety and
Imunogenicity of Double Viral Vaccine (MR) for
Measles and Rubella
2179515 Safety and Tolerability of a Modified
Vaccinia Ankara (MVA)-Based Vaccine Modified
to Express Brachyury and T-cell Costimulatory
2015104 Study of Bacillus Calmette-Guerin
(BCG) Combined With PANVAC Versus BCG
Alone in Adults With High Grade Non-Muscle
Invasive Bladder Cancer Who Failed At Least 1
Course of BCG
1991899 Study of Immunogenicity,
Reactogenicity and Safety of the Combined
Measles, Mumps and Rubella Vaccine
Produced by Bio-Manguinhos/Fiocruz in
Children 12-15 Months of Age, Followed by
Tetraviral Vaccine in Children 15-18 Months.
1813604 Immunogenicity of Inactivated and
Live Polio Vaccines
1635816 Immunogenicity of SA 14-14-2 JE
1581164 Studies of the Immune Response to
Vaccination After Hematopoietic Stem Cell
1313715 A Clinical Trial for Inactivated Vaccine
(Vero Cell) Against EV71 in Chinese Children
1267903 A Clinical Trial for Inactivated
Vaccine(Vero Cell) Against EV71 in Chinese
Healthy Young Adults and Children
922259 Safety and Immunogenicity of Live
Influenza A Vaccine for Avian Influenza H7N7
817661 Vitamin A and Maternal-infant Flu
764998 Influenza Vaccine in HIV
623753 Evaluate Tolerability of a
Multi-envelope, Prime-boost HIV Vaccine in
586469 A Randomized Study to Compare the
Safety and Immunogenicity of Fluviral® Made
With New Versus Aged Bulk